BET proteins inhibitor JQ1 impairs GM-CSF-promoted peritoneal macrophage self-renewal and IL-4-induced alternative polarization

Autor: Chen, Xue, Jiang, Qiong, Ren, Laibin, Ren, Hongyu, Xu, Haizhao, Wang, Jinyong, Wang, Pengbo, Chen, Shanze, Hua, Yuanqi, Ren, Sichong, Huang, Ning, Zhang, Lanlan, Xiao, Lijia

Publikováno v: In International Immunopharmacology November 2023 124 Part A

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]

Autor: Wang,Xiang, Hua,Yuanqi, Xu,Guangya, Deng,Senyi, Yang,Daoke, Gao,Xiang

Publikováno v: International Journal of Nanomedicine.

Wang X, Hua Y, Xu G et al. Int J Nanomedicine. 2019; 14:2637–2653. The authors advised that page 2641 contains the incorrect images of Figure 2B and Figure 2D due to an error in the program during the layout process.Read the original article.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dovemedicalp::fa55c33f4c8f09c4d735f95624a0711c
https://www.dovepress.com/corrigendum-targeting-ezh2-for-glioma-therapy-with-a-novel-nanopa-peer-reviewed-article-IJN

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction: Improved anti-tumor efficacy via combination of oxaliplatin and fibrin glue in colorectal cancer.

Autor: Hu Y; Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Yu T; Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Liu X; Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., He Y; Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Deng L; Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Guo J; Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Hua Y; Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Luo T; Department of Head & Neck and Mammary Oncology and Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China., Gao X; Department of Neurosurgery and Institute of Neurosurgery, State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu 610041, PR China.

Publikováno v: Oncotarget [Oncotarget] 2020 Sep 15; Vol. 11 (37), pp. 3484-3485. Date of Electronic Publication: 2020 Sep 15 (Print Publication: 2020).